Skip to main content

Clinical Trials Using Abatacept

Review the clinical trials studying abatacept on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-10 of 10

Abatacept Compared to Placebo for the Treatment of Immune Checkpoint Inhibitor Associated Myocarditis, ATRIUM Study
Status: Active
Location: 34 locations
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Status: Active
Location: 15 locations
Abatacept Extended Dosing Compared to Abatacept Short-Term Dosing for the Prevention of Graft versus Host Disease, ABA3 Study
Status: Active
Location: Boston Children's Hospital, Boston, Massachusetts
Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
Status: Active
Location: Yale University, New Haven, Connecticut
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Status: Active
Location: Yale University, New Haven, Connecticut
Ruxolitinib with or without Abatacept for the Prevention of Graft Versus Host Disease and Cytokine Release Syndrome after T-cell Haploidentical Stem Cell Transplant in Patients with Hematologic Malignancies
Status: Active
Location: Siteman Cancer Center at Washington University, Saint Louis, Missouri
Azacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma
Status: Temporarily Closed to Accrual
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Belumosudil for the Prevention of Graft-versus-Host Disease after Donor Hematopoietic Cell Transplant
Status: Active
Location: 8 locations
Abatacept in Combination with Mycophenolate Mofetil and Tacrolimus for the Prevention of Graft-versus-Host Disease after Omidubicel Hematopoietic Cell Transplant
Status: Active
Location: Duke University Medical Center, Durham, North Carolina
Abatacept for the Prevention of Graft Versus Host Disease after Cord Blood Transplant in Patients with Hematologic Blood Cancers, ABBA CORD Trial
Status: Temporarily Closed to Accrual
Location: Case Comprehensive Cancer Center, Cleveland, Ohio